Back to PollNow

Back to companies

Inmune Bio, Inc.

INMBUSNASDAQPharmaceuticals & Healthcare

Inmune Bio, Inc.

Revenue

$50,000

YoY +257.1%

Operating income

-$47.4mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API